
Print (Copy)
From the dawn of time, man has communicated through writing. Whether it's coal scrawled onto cave walls, laying quill and ink onto vellum, or laser printing to paper nothing compares to feeling and holding the words of another writer.

Aveed journal ad (Copy)
One of my concepts (thus repeated on that page of this Website, too) that was turned into a real journal ad.

HALAVEN Journal Ad (Copy)
This spread ad displays the emotional campaign headline and imagery at left and key takeaways and a recommendation at right for this treatment for metastatic breast cancer.

The Beacon newsletter (Copy)
This newsletter provides useful information for people with cystic fibrosis and their caregivers including lifestyle tips, personal profiles, and healthy recipes.

Kovaltry global HCP visual aid (Copy)
Pharmacokinetics (PK) is a different clinical marker that describes the effectiveness of this product used to treat hemophilia. Clinical and population PK are detailed on this spread.

BPDCN Diagnostic Algorithm for Skin Presentations (Copy)
Dermatopathologists run biopsy samples through a sequence of immunohistochemistry (IHC) panels. The page at left represents how an initial panel would be analyzed. The page at right is summary of all the steps in the dermatopathologist’s algorithm.

Kovaltry pediatric standalone (Copy)
The efficacy spread comprehensively captures different measurements of annualized bleeding rate, including type, age group, or dosing regimen.

Unbranded oncology convention panel (Copy)
Multiple myeloma is a complicated subject matter in its own. This paradigm-based design conveys in an easy-to-follow format how the definitions of response in treating multiple myeloma have changed.

Mirena journal ad (Copy)
We all lead busy lives and often have a lot on our minds. Using an intrauterine device means one less thing to worry about fitting into a packed schedule.

Saflutan journal ad (Copy)
Preservative free anti-glaucoma treatment doesn't mean settling for weaker efficacy. Powerful reduction of dangerous intraocular pressure can be achieved with this new prostaglandin.